SCHEMBL6478244

SCHEMBL6478244

NC(=O)[C@H]1CN2C(=O)N(c3cc(Cl)nc(Cl)c3)C(=O)[C@]2(Cc2ccc(OC(F)(F)F)cc2)C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN3 Q9UGI6 1/20 0.34
METAP2 P50579 1/20 0.34
LIPE Q05469 2/20 0.34
GCGR P47871 3/20 0.33
HTR2C P28335 1/20 0.33
CXCR3 P49682 1/20 0.33
MCHR1 Q99705 1/20 0.33
EPHX2 P34913 1/20 0.33
AMPD2 Q01433 1/20 0.33
PANK3 Q9H999 1/20 0.33
MAPT P10636 1/20 0.33
PPARD Q03181 2/20 0.33
PPARA Q07869 2/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
OPRL1 P41146 1/20 0.33
TEAD1 P28347 1/20 0.33
PPARG P37231 1/20 0.32
HCRTR1 O43613 1/20 0.32
HCRTR2 O43614 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841580 0.92 METAP2 (0.39) METAP2LIPEGCGRHTR2CAMPD2
SCHEMBL14254846 0.90 GCGR (0.35) KCNN3METAP2LIPEGCGRHTR2C
SCHEMBL6485047 0.89 MCHR1 (0.35) KCNN3METAP2LIPEGCGRMCHR1
SCHEMBL6477360 0.89 GCGR (0.35) KCNN3METAP2LIPEGCGREPHX2
SCHEMBL4847817 0.88 KCNN3 (0.38) KCNN3METAP2LIPEGCGRHTR2C
SCHEMBL14254710 0.88 KCNN3 (0.36) KCNN3METAP2LIPEGCGRHTR2C
SCHEMBL4845117 0.88 KCNN3 (0.36) KCNN3METAP2LIPEGCGRHTR2C
SCHEMBL4848707 0.88 KCNN3 (0.36) KCNN3METAP2LIPEGCGRHTR2C
SCHEMBL14254709 0.86 GRM2 (0.37) KCNN3LIPEHTR2CHCRTR1HCRTR2
SCHEMBL4848518 0.85 CCR5 (0.34) KCNN3METAP2LIPEGCGRCXCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342012-B2 Inhibitors of αLβ2 mediated cell adhesion MITSUBISHI TANABE PHARMA CORPORATION (JP) 2008-03-11 US disclosed
US-7342012-B2 Inhibitors of αLβ2 mediated cell adhesion MITSUBISHI TANABE PHARMA CORPORATION (JP) 2008-03-11 US disclosed
US-6897225-B1 Inhibitors of αLβ2 mediated cell adhesion TANABE SEIYAKU CO., LTD. (JP) 2005-05-24 US disclosed